Einsatz von Rituximab in der Behandlung neuroimmunologischer Erkrankungen | SpringerLink
Anti-Rituximab (CD20) Antibody (Fc Reduced) | Assay Genie
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab | Science
B-lymphocyte Antigen CD20 Epitope Peptide Fragment, Bound To Rituximab (Fab Fragment). Indications for Rituximab Include Leukemia Stock Illustration - Illustration of rheumatoid, cd20: 188464549
An analysis of Rituximab dose reduction & CD 19 monitoring
Frontiers | Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives
Far- and near-UV CD spectra of (a) Rituximab and (b) Etanercept... | Download Scientific Diagram
Rituximab for the treatment of multiple sclerosis: a review | SpringerLink
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial - The Lancet Rheumatology
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Blog - Deciphering B Cell Cancers With a Rituximab Biosimilar
Higher order structure analyzed by CD, FT-IR and DSC for CT-P10,... | Download Scientific Diagram
The proposed mechanisms of action for rituximab, a chimeric monoclonal... | Download Scientific Diagram
Rituximab Gains Expanded Approval in Pediatrics - Vasculitis Foundation
Frontiers | A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
How a Third COVID Vaccine Dose Affects People Taking Rituximab
Drug Repurposing for CD - CDCN
What is RITUXAN® (rituximab) for GPA and MPA?
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Rituximab in nephrology
B-lymphocyte Antigen CD20 Epitope Peptide Fragment, Bound To Rituximab (Fab Fragment). Indications for Rituximab Include Leukemia Stock Illustration - Illustration of surface, acid: 188464558
The superimposed far-UV CD spectral region from 205 to 250 nm of 3 lots... | Download Scientific Diagram
Efficacy and Toxicity of Rituximab in Multiple Sclerosis | Archives of Neuroscience | Full Text
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab - ScienceDirect
Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies | Revista Iberoamericana de Micología
